Ron Wolchinsky

Ron joined Enara Bio in 2021 to lead the molecular immunology research efforts for the company, building on a decade of academic and industry experience.

Prior to joining Enara Bio, Ron spent over six years at Adaptimmune developing novel TCR therapies. During this time, he led teams in Protein Sciences tasked with isolation, identification and characterisation of target specific TCRs, and Next Generation Research, where he led projects aimed at improving cell therapy products. Prior to his time at Adaptimmune, Ron held post-doctoral fellowships at The Weatherall Institute of Molecular Medicine at Oxford University and the at the Technion – Israel’s Institute of Technology.

Ron holds a PhD in Molecular Immunology from the Technion – Israel’s Institute of Technology.